Updates and news related to prostate cancer:
Late luteinizing hormone-released hormones (LHRH) injections cause spike in testosterone levels in prostate cancer
Read this OncLive article by Brittany Cote.
Prostate cancer metastases linked to revival of dormant molecular program
Data confirm decades-old hypothesis that metastatic disease hijacks tissue-specific developmental programs
Biomarker-driven monotherapy enters non-metastatic castration-resistant prostate cancer (nmCRPC) paradigm
Olaparib is now available for patients with nmCRPC whose tumor harbors certain mutations.
Routine use of neoadjuvant Docetaxel plus ADT not supported in localized, high-risk prostate cancer
Read this article in Renal & Urology News.
UCLA researches find cryotherapy as an effective treatment for men with intermediate-risk prostate cancer
UCLA Health news release
Evaluation of use of shorter radiation regimens for breast and prostate cancer in the US
Shorter radiation treatment regimens are evidence-based practices that are similarly effective and safe.
Biochemically recurrent prostate cancer and targeted PET imaging agent
Patient enrollment now underway in Phase 3 SPOTLIGHT as well as LIGHTHOUSE clinical trials in prostate cancer
New treatment and clinical trials
The use of genetic information to attack cancers: Prostate Health Education Network video
Inherited origins of prostate cancer
Vanderbilt researchers have identified ancestral fragments of DNA associated with hereditary prostate cancer.
Treatment hope as scientists find gene that powers spread of prostate cancer
The protein makes tumors more aggressive, helping them migrate to other organs.